United States Cancer Antibody Market, Drug Price, Sales & Clinical Trials Insight 2021-2026
14 avr. 2021 04h18 HE
|
Research and Markets
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "US Cancer Antibody Market, Drug Price, Sales & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. Over...
AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for Grade 1 Immune Checkpoint Inhibitor-Associated Colitis
13 avr. 2021 08h30 HE
|
AzurRx BioPharma, Inc.
DELRAY BEACH, Fla., April 13, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development...
Insights on the Cancer Biological Toxins Drug Global Market to 2026 - by Phase, Status, Cancer Type and Countries
04 févr. 2021 07h48 HE
|
Research and Markets
Dublin, Feb. 04, 2021 (GLOBE NEWSWIRE) -- The "Global Cancer Biological Toxins Drug Market Opportunity, Drug Sales & Clinical Trials Insight 2026" report has been added to...
Global Gastric Cancer Forecast and Market Analysis Report 2020-2027 - Trastuzumab Biosimilars are Now Available, Leading to a Sharp Decline in the Market Share of Herceptin
28 janv. 2021 06h33 HE
|
Research and Markets
Dublin, Jan. 28, 2021 (GLOBE NEWSWIRE) -- The "Gastric Cancer Forecast and Market Analysis" drug pipelines has been added to ResearchAndMarkets.com's offering. The report estimates that in 2018,...
AzurRx BioPharma Announces $8.0 Million Offerings
04 janv. 2021 07h00 HE
|
AzurRx BioPharma, Inc.
DELRAY BEACH, Fla., Jan. 04, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a company specializing in the development of non-systemic,...
Global Checkpoint Inhibitors Market Report 2020-2030: COVID-19 Growth and Changes
22 déc. 2020 05h23 HE
|
Research and Markets
Dublin, Dec. 22, 2020 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. ...
Immune Checkpoint Inhibitors Market, 2025
30 oct. 2020 04h53 HE
|
Research and Markets
Dublin, Oct. 30, 2020 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The...
Global PD-1/PD-L1 Immunotherapy Market Analysis and Forecast, 2019-2020 & 2030
23 oct. 2020 04h53 HE
|
Research and Markets
Dublin, Oct. 23, 2020 (GLOBE NEWSWIRE) -- The "Global PD-1/PD-L1 Immunotherapy Market: Focus on Type, Application, Country Data (14 Countries), and Competitive Landscape - Analysis and Forecast,...
Global Immunotherapy in Oncology Startup Identification Report 2020: Over 110 Startups Working in the Field of Onco-Immunotherapy
15 sept. 2020 05h43 HE
|
Research and Markets
Dublin, Sept. 15, 2020 (GLOBE NEWSWIRE) -- The "Immunotherapy in Oncology Startup Identification" report has been added to ResearchAndMarkets.com's offering. Cancer Immunotherapy is a very dynamic...